VitamFero Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Liquidation

VitamFero General Information

Description

Developer of anti-infective vaccines intended to offer treatment to the people in France. The company's vaccines are based on a patented technology that designs, develops, registers and commercializes it, enabling physicians to offer remedy against pests of the family Apicomplexa.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 8 rue André Le Nôtre
  • 49100 Angers
  • France
+33 02 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VitamFero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 04-Jul-2018 00.000 Completed Bankruptcy: Liquidation
4. Grant 20-Jan-2016 000.00 00.000 Completed Generating Revenue
3. Later Stage VC (Series C) 28-May-2015 00.00 00.000 Completed Generating Revenue
2. Later Stage VC 22-Feb-2011 $1.5M $1.86M Completed Generating Revenue
1. Seed Round 29-Sep-2009 $360K $360K Completed Startup
To view VitamFero’s complete valuation and funding history, request access »

VitamFero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of anti-infective vaccines intended to offer treatment to the people in France. The company's vaccines are bas
Discovery Tools (Healthcare)
Angers, France
14 As of 2017
00.000
000000000000 00.000

000 0000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000

0000000

e eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offici
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VitamFero Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

VitamFero Executive Team (3)

Name Title Board Seat Contact Info
Edouard Seche Scientific Director
Pascal Breton Ph.D President, Managing Director & Chief Executive Officer
You’re viewing 2 of 3 executive team members. Get the full list »

VitamFero Board Members (6)

Name Representing Role Since
Alexandre Levert VitamFero Board Member 000 0000
François Guillemin VitamFero Board Member 000 0000
You’re viewing 2 of 6 board members. Get the full list »

VitamFero Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial